Literature DB >> 12218796

A case of synovial chondromatosis of the TMJ: treatment based on stage of the disease.

Mustafa Asim Aydin1, Atilla Kurtay, Selim Celebioglu.   

Abstract

A patient with synovial chondromatosis of the temporomandibular joint extending to the preauricular skin, parotid, and infratemporal fossa was operated and followed with a stable remnant, for 2 years postoperatively. In light of literature and what the authors have learned from this case, the authors emphasize stage of the disease as a risk factor for recurrence. The long history of symptoms, calcified and conglomerated radiological appearance of the lesion, and extensive involvement of the joint and periarticular area of this case indicate a late-stage disease in which the metaplastic activity dwindles. For late stages, the authors suggest a conservative approach that will only provide symptom relief and prevent secondary joint deformity to avoid potential complications and morbidities of a more extensive surgery.

Entities:  

Mesh:

Year:  2002        PMID: 12218796     DOI: 10.1097/00001665-200209000-00014

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  3 in total

1.  [Joint loose bodies in the mandible. Diagnostic criteria and pathways for therapy planning].

Authors:  H E Umstadt; B Kusch
Journal:  Mund Kiefer Gesichtschir       Date:  2003-11-08

2.  Synovial chondromatosis of the right side temporomandibular joint extending to the middle cranial fossa: A case report with 7-year postoperative follow up and expression of a biomarker of cell proliferative activity.

Authors:  Hiroyuki Yoshitake; Kou Kayamori; So Wake; Fumiaki Sato; Koji Kino; Kiyoshi Harada
Journal:  Int J Surg Case Rep       Date:  2016-01-25

3.  Bilateral synovial chondromatosis of the elbow in an adolescent: a case report and literature review.

Authors:  Jianming Mo; Jie Pan; Yun Liu; Wenyu Feng; Boxiang Li; Kai Luo; Weijia Mo; Huahao Lin; Shijie Liao
Journal:  BMC Musculoskelet Disord       Date:  2020-06-13       Impact factor: 2.362

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.